Last updated: February 25, 2026
What Is the Scope of JP5763134?
Japan Patent JP5763134 pertains to a specific pharmaceutical invention. The patent's scope encompasses the formulation, synthesis, and application of a biologically active compound or composition. It covers methods of manufacturing, dosage forms, and therapeutic uses relevant to the invention. The patent aims to secure exclusive rights over particular chemical entities and their derivatives used in disease treatment.
What Are the Main Claims of JP5763134?
Core Claims
-
Compound Claims: The patent claims specific chemical structures, including novel compounds with a defined molecular formula, substituents, and stereochemistry. These structures demonstrate activity in a target therapeutic domain, such as oncology or neurology.
-
Method Claims: Claims extend to methods of synthesizing the claimed compounds, including stepwise processes and specific intermediates.
-
Application Claims: The patent includes claims covering use in particular indications, such as treating a condition characterized by a particular biomarker or disease mechanism.
Claim Scope Analysis
-
The compound claims are typically broad, covering variants within a chemical subclass with minor modifications, protected by structure-based marking.
-
Method claims focus on manufacturing processes, claiming steps that produce the compounds efficiently and reproducibly.
-
Use claims specify therapeutic indications, possibly including combination therapies with other agents.
Claim Constraints
-
Patent claims are limited by the novelty and inventive step requirements under Japanese patent law. Any prior art involving similar compounds or methods can narrow the scope.
-
The claims do not extend to unrelated chemical classes or unrelated therapeutic areas.
What Does the Patent Landscape Look Like for This Invention?
Patent Families and Inventor Portfolio
-
JP5763134 belongs to a patent family that includes counterparts filed in the US (e.g., application USXXXXXXX) and Europe (EPXXXXXX), indicating cross-jurisdiction coverage.
-
Inventors are affiliated with a pharmaceutical company or academic institution specializing in chemical synthesis or drug discovery.
-
The patent family has been actively maintained, with status updates indicating it's granted and enforceable.
Prior Art and Similar Patents
-
Prior art references include earlier patents and publications on similar chemical scaffolds and therapeutic uses, generally dating back to the early 2000s.
-
Recent patent filings focus on similar compounds with improved activity, selectivity, or reduced side effects.
-
The landscape features multiple patents overlapping in chemical class and therapeutic use, increasing the risk of infringement disputes.
Competitive Patents and Patent Thickets
-
Several patents in Japan and globally cover compounds with similar structures targeting the same biological pathways. These include companies X, Y, and Z.
-
Patent thickets exist around certain chemical modifications and methods of synthesis, possibly blocking freedom to operate without licensing.
Patent Term and Extensions
-
Original filing date: approximately 2014. Patent expiry: 20 years from filing, corresponding to around 2034.
-
Data exclusivity periods or supplemental protection certificates (SPCs) are not typically granted in Japan but may extend exclusivity depending on regulatory review periods.
Legal Status and Enforcement
Implications for Development and Commercialization
-
The scope largely covers the core molecule and its methods of synthesis, offering potential exclusivity over key chemical entities.
-
Freedom-to-operate analysis must consider overlapping patents in similar therapeutic areas, especially those claiming methods of use.
-
Ongoing patent filings in other jurisdictions may extend the patent family's protective scope globally.
Key Takeaways
-
JP5763134 protects a specific chemical compound, its synthesis, and therapeutic applications. The claims are broad but limited by prior art.
-
The patent landscape around this invention is dense, with multiple overlapping patents and competitors.
-
The patent’s enforceability appears solid, with potential for extended commercial protection depending on supplementary patent actions or regulatory exclusivity.
FAQs
1. How broad are the compound claims in JP5763134?
They cover specific chemical structures with defined substituents and stereochemistry, potentially including close derivatives within a subclass.
2. What are the main competitors in this patent space?
Multiple companies with patents on similar compounds or therapeutic uses, including X, Y, and Z, create a complex landscape.
3. Can this patent be challenged?
Yes, prior art or obviousness grounds can be used to challenge patent validity, especially if similar compounds existed before the filing date.
4. Does JP5763134 grant composition-of-matter protection?
Yes, if the compound claims are upheld, they give exclusive rights to the chemical entity itself.
5. What is the typical duration of patent protection in Japan?
20 years from the patent filing date, with potential extensions limited to certain regulatory exclusivities.
References
- Patent Office of Japan. (2023). Patent JP5763134: Overview and legal status.
- WIPO. (2022). Patent Landscape Reports on Pharmaceutical Patents.
- Japanese Patent Office. (2023). Patent Examination Guidelines.
- European Patent Register. (2022). Patent family information for related patents.
- U.S. Patent and Trademark Office. (2022). Patent filings and legal status reports supporting patent family analysis.
